PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
19-Oct-2020 Vaccine research shows promise as need grows with second waves of COVID-19, says GlobalData GlobalData
19-Oct-2020 UCB FURTHER INVESTS IN UK OPERATIONS WITH AGREEMENT TO ACQUIRE A NEW LEADING-EDGE CAMPUS UCB
19-Oct-2020 Approvals of COVID-19 biologics will put huge pressure on large-scale bioprocessing networks, according to CPhI Annual Report CPhI
19-Oct-2020 Janssen Receives CHMP Positive Opinion for Expanded Use of TREMFYA®▼ (guselkumab) in the Treatment of Active Psoriatic Arthritis (PsA) in the European Union (EU) Janssen
15-Oct-2020 Transgene and BioInvent to present data on oncolytic virus BT-001 at the SITC 35th Anniversary Annual Meeting Transgene and BioInvent
14-Oct-2020 Oxurion NV appoints Tom Graney, CFA as Chief Financial Officer Oxurion NV
14-Oct-2020 Vitalograph Launch Powerful New In2itive e-Diary for Global Clinical Trials Vitalograph
13-Oct-2020 Safety and Efficacy of Subcutaneous Entyvio® (Vedolizumab) Sustained During Long-term Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis Porter Novelli
13-Oct-2020 Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020 Verona Pharma
13-Oct-2020 F4 Pharma Announces Formation of Scientific Advisory Board F4 Pharma
13-Oct-2020 Prestige Biopharma Receives Positive EMA Opinion on Orphan Designation for PBP1510 for Treatment of Pancreatic Cancer Prestige Biopharma
13-Oct-2020 Hofseth BioCare ASA: PROGO®’s BIOACTIVE PEPTIDES™ TO SUPPORT HEALTHY IRON LEVELS TO BE LAUNCHED IN THE U.S. Hofseth BioCare
13-Oct-2020 SHIONOGI ANNOUNCES PUBLICATION OF TWO STUDIES IN THE LANCET INFECTIOUS DISEASES HIGHLIGHTING THE EFFICACY AND SAFETY OF CEFIDEROCOL FOR THE TREATMENT OF INFECTIONS DUE TO AEROBIC GRAM-NEGATIVE BACTERIA IN ADULTS WITH LIMITED TREATMENT OPTIONS Shionogi
13-Oct-2020 New Device for Detecting Traumatic Brain Injury ‘On the Spot’ University of Birmingham
13-Oct-2020 PHASE 2B/3 TRIAL SHOWS EFFICACY OF FILGOTINIB FOR THE INDUCTION AND MAINTENANCE OF REMISSION IN MODERATELY AND SEVERELY ACTIVE Ketchum
13-Oct-2020 Scottish Medicines Consortium Accepts DARZALEX®▼ (daratumumab) Subcutaneous Injection and IMBRUVICA® (ibrutinib) Combination Therapy for Treatment of Blood Cancers in Scotland Scottish Medicines Consortium
13-Oct-2020 Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis Evelo Biosciences
13-Oct-2020 Evelo Biosciences Treats First Patients in Phase 2 Dose-Ranging Trial of EDP1815 for the Treatment of Psoriasis Evelo Biosciences
13-Oct-2020 ProductLife Group Acquires Axpharma in Response to Accelerating Global Demand for Pharmacovigilance Support ProductLife Group
12-Oct-2020 Sanifit to Present New Data on SNF472 for Vascular Calcification at the American Society of Nephrology Kidney Week 2020 Sanfit